Drugs / Tdap
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01461980 Comparator | Sep 2011 → May 2014 | meningococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tdap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01461980 ↗ |
| Modality | Vaccine | “Tdap (diphtheria, tetanus, and acellular pertussis)” NCT01461980 ↗ |